CH504869A - Verfahren zur Herstellung von stabilen Lösungen des Proscillaridins - Google Patents
Verfahren zur Herstellung von stabilen Lösungen des ProscillaridinsInfo
- Publication number
- CH504869A CH504869A CH1824466A CH1824466A CH504869A CH 504869 A CH504869 A CH 504869A CH 1824466 A CH1824466 A CH 1824466A CH 1824466 A CH1824466 A CH 1824466A CH 504869 A CH504869 A CH 504869A
- Authority
- CH
- Switzerland
- Prior art keywords
- proscillaridin
- proscillaridine
- phenyl
- hydroxy
- therapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEB0085102 | 1965-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH504869A true CH504869A (de) | 1971-03-31 |
Family
ID=6982752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1824466A CH504869A (de) | 1965-12-22 | 1966-12-21 | Verfahren zur Herstellung von stabilen Lösungen des Proscillaridins |
Country Status (7)
| Country | Link |
|---|---|
| BE (1) | BE691525A (enrdf_load_stackoverflow) |
| CH (1) | CH504869A (enrdf_load_stackoverflow) |
| DE (1) | DE1467801A1 (enrdf_load_stackoverflow) |
| ES (1) | ES334627A1 (enrdf_load_stackoverflow) |
| FR (1) | FR7014M (enrdf_load_stackoverflow) |
| GB (2) | GB1173322A (enrdf_load_stackoverflow) |
| NL (2) | NL6617599A (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4536236A2 (en) * | 2022-06-06 | 2025-04-16 | University of Utah Research Foundation | Methods of modulating atxn2 expression |
-
1965
- 1965-12-22 DE DE19651467801 patent/DE1467801A1/de active Pending
-
1966
- 1966-12-01 GB GB2723569A patent/GB1173322A/en not_active Expired
- 1966-12-01 GB GB5394166A patent/GB1173321A/en not_active Expired
- 1966-12-14 NL NL6617599A patent/NL6617599A/xx unknown
- 1966-12-17 ES ES334627A patent/ES334627A1/es not_active Expired
- 1966-12-20 FR FR88166A patent/FR7014M/fr not_active Expired
- 1966-12-20 BE BE691525D patent/BE691525A/xx unknown
- 1966-12-21 CH CH1824466A patent/CH504869A/de not_active IP Right Cessation
-
1971
- 1971-02-09 NL NL7101670A patent/NL7101670A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL6617599A (enrdf_load_stackoverflow) | 1967-06-23 |
| FR7014M (enrdf_load_stackoverflow) | 1969-06-09 |
| BE691525A (enrdf_load_stackoverflow) | 1967-06-20 |
| ES334627A1 (es) | 1968-03-16 |
| GB1173322A (en) | 1969-12-10 |
| NL7101670A (enrdf_load_stackoverflow) | 1971-05-25 |
| GB1173321A (en) | 1969-12-10 |
| DE1467801A1 (de) | 1968-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2635853C2 (de) | Pyrrolidin-2-on-Derivate und diese enthaltende Arzneimittel | |
| DE2902506A1 (de) | Verwendung von nicht oder nur gering irritierenden und/oder promovierenden diterpenalkoholen und von derivaten davon als antineoplastische mittel | |
| CH510625A (de) | Verfahren zur Herstellung von neuen 1-(3',5'-Dihydroxy- bzw. -acyloxy-phenyl)-2-aminoäthanolen und deren physiologisch verträglichen Säureadditionssalzen | |
| DE3033897C2 (enrdf_load_stackoverflow) | ||
| DE2360332C2 (de) | Die Verwendung von 1-Carnitin oder einem 1-Carnitinderivat oder eines Salzes davon bei der Behandlung spezieller Lungenkrankheiten | |
| DE1815808A1 (de) | Benzolderivate | |
| CH504869A (de) | Verfahren zur Herstellung von stabilen Lösungen des Proscillaridins | |
| EP0234019B1 (de) | Verwendung von wässrigen Auszügen von Epilobium angustifolium L. zu einer neuen medizinischen Indikation | |
| DE1670378A1 (de) | Verfahren zur Herstellung einer Verbindung aus Phenylbutazon und ss-Diaethylaminoaethylamid der p-Chlorphenoxyessigsaeure | |
| DE2351292C3 (de) | 2,10-Dichlor-6-äthoxycarbonyl-12-methyl-12H-dibenzo[d,g][1,3]dioxocin und Verfahren zu dessen Herstellung sowie diese Verbindung enthaltende Arzneimittel | |
| DE2436234A1 (de) | 3,20-dioxo-16alpha-methyl-pregna1,4,9(11)-triene als arzneimittel, neues verfahren zur herstellung dieser verbindungen und pharmazeutische zusammensetzungen | |
| DE1518444C (de) | erythro alpha Phenyl beta amino propanole, Verfahren zu ihrer Herstellung und solche Verbindungen enthaltende Arz neimittel | |
| DE2953014A1 (en) | Osteoplastic promotor | |
| AT223746B (de) | Verfahren zur Herstellung neuer Strophanthidolglykoside | |
| DE1767666B2 (de) | Pharmazeutische Zubereitung gegen , Lebererkrankungen | |
| DE1468554C (de) | 20 beta tert Amino 3 alpha hydroxy (bzw acyloxy) 5 beta pregnane bzw de ren Salze sowie Verfahren zu ihrer Her stellung | |
| DE1467743A1 (de) | Verfahren zur Herstellung eines Praeparats mit verlaengerter Vitamin B 12-Wirkung | |
| EP0443198B1 (de) | Diterpene mit immunmodulatorischer Wirkung | |
| AT282055B (de) | Verfahren zur Herstellung neuer Valepotriate | |
| DE1445558C3 (de) | Piperid-2 -yl-1,3-dioxolane | |
| DE2237407A1 (de) | Magnesiumsalze, ihre verwendung und verfahren zu ihrer herstellung | |
| DE1468554B1 (de) | 20beta-tert.-Amino-3alpha-hydroxy-(bzw.-acyloxy)-5beta-pregnane bzw. deren Salze sowie Verfahren zu ihrer Herstellung | |
| AT267760B (de) | Verfahren zur Herstellung von neuen 4'-Monoestern von Cymarol | |
| DE1468919C (de) | 3,11 Dioxo steroid 4,9 diene und ein Verfahren zu ihrer Herstellung | |
| DE973048C (de) | Verfahren zur Herstellung von als Heilmittel geeigneten substituierten Morpholinen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |